Multiple sclerosis (MS) is a chronic, immune-mediated disease in which early, individualized disease-modifying therapy (DMT) can reduce disease activity, delay disability progression, and preserve quality of life. As therapeutic options expand particularly multiple anti-CD20 therapies with different dosing schedules, administration routes, and safety considerations clinicians must accurately interpret trial and real-world data, weigh risk benefit trade-offs, and align recommendations with patient goals. Inconsistent application of evidence-based MS management guidelines and variability in monitoring practices can contribute to suboptimal therapeutic outcomes, especially in older and pediatric patients, whose physiological and social considerations may affect tolerability, adherence, and long-term disease control. In this CMEO BriefCase, expert faculty will walk learners through a real-world case, stopping for strategic discussions on the assessment of data on available anti-CD20 therapies to make appropriate recommendations for patients with MS, utilization of evidence-based guidelines for MS management to optimize treatment selection and monitor therapeutic outcomes, and the development of tailored MS treatment plans to address the unique physiological and social needs of older and pediatric patients.
Credit & MOC Details
Credit information is provided by the course provider. We recommend confirming credit eligibility with the provider or your licensing board before starting the activity.
Credit types
MOC types
FDA REMS
Qualifies for MIPS
Target Specialties
Pricing
CME included with membership
| Integrative Psychiatry Certificate Program | $3,350 |
Collected from the provider’s public pages · source
Specialties served/covered
- Addiction Medicine
- Addiction Psychiatry
- Adolescent Medicine
- Allergy & Clinical Immunology
- Cardiovascular Disease
- Communication & Shared Decision-Making
- Critical Care Medicine
- Diagnostic Radiology
- Emergency Medicine
- Endocrinology, Diabetes & Metabolism
- Family Medicine
- Gastroenterology
- General & Adult Psychiatry
- General Internal Medicine
- General Operative Anesthesia
- General Otolaryngology
- General Pediatrics
- General Surgery
- Gynecologic Oncology
- Hematology
- Hospice & Palliative Medicine
- Medical Oncology
- Mood & Anxiety Disorders
- Neonatal-Perinatal Medicine
- Neurology
- Neuromuscular Medicine
- Neuroradiology
- Nuclear Medicine
- Obstetrics & Gynecology
- Ophthalmology
- Orthopaedic Surgery
- Pain Medicine
- Physical Medicine & Rehabilitation
- Practice Management & Ethics
- Primary Care Sports Medicine
- Pulmonary Disease
- Radiation Oncology
- Regional Anesthesia & Acute Pain
- Rheumatology
- Sleep Medicine
- Surgical Oncology
- Thoracic Surgery
- Urological Oncology
- Anesthesiology
- Cardio-Vascular
- Cross-Specialty
- Emergency & Critical Care
- ENT & Head Neck
- GI & Liver
- Infectious Disease
- Internal Medicine
- Medical Subspecialties
- Neurology
- Ob/Gyn
- Oncology & Hematology
- Orthopedics
- Pain & Palliative
- Pediatrics
- Primary care
- Psychiatry
- Radiology
- Rehabilitation
- Sports & Exercise Medicine
- Surgery
- Urology
- No reviews yet. Be the first to share yours.
Pricing
Free
Reported to ACCME by the provider
- On-demand / recorded video
- Credit · Up to 1 credit
- MOC · Up to 1 point
- Commercial Support
-
ReleasedFeb 27, 2026
-
Last day to claim creditFeb 28, 2027 5 months left
-
Efficient CME, CME Outfitters, LLC Livestream: Treating All of MS: Unifying Strategies to Target Relapse and Progression in a Shifting Clinical Landscape
-
Efficient CME, CME Outfitters, LLC Treating All of MS: Unifying Strategies to Target Relapse and Progression in a Shifting Clinical Landscape
-
Efficient CME, CME Outfitters, LLC From Trial to Treatment: Using Modern Evidence, Expert Insight, and Practice Simulation to Navigate the Integration of Bispecific Antibodies into the Care of Patients with Multiple Myeloma
